从“卖水人”到“矿主”:CXO价值的意外漂移

医药财经
Jan 22

昭衍新药的2025年业绩预告里,实验室服务亏损过亿,但账上一群“会呼吸的资产”——实验用猴,却通过公允价值变动贡献了近5亿利润,硬生生把净利润拉成三位数增长。昭衍新药的财报表述平静而专业:公司预计2025年度净利润同比增长214%至371%,其中生物资产公允价值变动贡献净利润4.52至4.99亿元。而同期公司实验室服务及其他业务则录得净亏损1.30至2.06亿元。01 戏剧转折2025年初,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10